BD (NYSE: BDX) announced today that it received CE mark approval for its Revello vascular covered stent system.

Boston Scientific Corp BSX on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems from clinical settings following reports of deployment complications ...

FDA flags safety risk with Boston Scientific stents after reports of deployment issues causing deaths and injuries, prompting a Class I recall.

Boston Scientific has issued an FDA warning letter recommending removal of 1,660 lots of AXIOS Stent and Electrocautery Enhanced Delivery Systems due to increased reports of stent deployment and ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained ...

Please provide your email address to receive an email when new articles are posted on . A new tapered configuration of transcarotid stent system was launched in the U.S. The system indicated for ...

Please provide your email address to receive an email when new articles are posted on . A carotid artery stenting system was linked to low event rates at 1 year. The device consists of an embolic ...

The U.S. Food and Drug Administration (FDA) said it is aware that Boston Scientific Corporation (NYSE: BSX) has alerted customers to remove certain AXIOS stents and electrocautery-enhanced delivery ...

CHICAGO, Oct 17 (Reuters) - Abbott Laboratories Inc said on Friday that the U.S. Patent and Trademark Office had temporarily extended its Yock patent for the delivery of stents. The decision sent ...

Improving stent implantation techniques has become critical, especially with the advent of new and highly effective stents and delivery systems. The development of new systems with improved ...

New York, NY - Competing device companies and /Johnson & Johnson have entered into an agreement to copromote the Cypher TM sirolimus-eluting stent in the US, with the option to embark on a similar ...